Bristol-Myers Squibb Company Announces Specialty Pharmacy Patient Management Programs for Sprycel?? (dasatinib) Patients
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka America Pharmaceutical, Inc. today announced the launch of patient management programs for Sprycel (dasatinib) pat…Tags: bristol myers squibb, bristol myers squibb company, dasatinib, Management, Myers, otsuka america pharmaceutical inc
